MFAP5
Basic information
Region (hg38): 12:8637346-8662888
Links
Phenotypes
GenCC
Source:
- aortic aneurysm, familial thoracic 9 (Moderate), mode of inheritance: AD
- aortic aneurysm, familial thoracic 9 (Limited), mode of inheritance: AD
- familial thoracic aortic aneurysm and aortic dissection (Supportive), mode of inheritance: AD
- aortic aneurysm, familial thoracic 9 (Strong), mode of inheritance: AD
- familial thoracic aortic aneurysm and aortic dissection (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Aortic aneurysm, familial thoracic 9 | AD | Cardiovascular | Individual have been described with aortic dilatation and arrhthymias, and awareness may allow surveillance and early medical and/or surgical management, which may reduce morbidity and mortality | Cardiovascular | 25434006 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MFAP5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 32 | 34 | ||||
missense | 83 | 87 | ||||
nonsense | 5 | |||||
start loss | 1 | |||||
frameshift | 4 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 8 | |||||
splice region | 7 | 5 | 2 | 14 | ||
non coding | 40 | 37 | 80 | |||
Total | 0 | 4 | 104 | 76 | 37 |
Variants in MFAP5
This is a list of pathogenic ClinVar variants found in the MFAP5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-8647970-A-G | Benign (Jun 23, 2018) | |||
12-8648077-C-G | Likely benign (Aug 23, 2017) | |||
12-8648087-A-G | not specified | Benign/Likely benign (Aug 03, 2024) | ||
12-8648094-C-T | Likely benign (Jun 02, 2021) | |||
12-8648100-A-T | not specified | Uncertain significance (Jun 09, 2024) | ||
12-8648101-T-C | Cardiovascular phenotype | Conflicting classifications of pathogenicity (May 23, 2023) | ||
12-8648104-G-A | Uncertain significance (Mar 04, 2023) | |||
12-8648106-T-C | Cardiovascular phenotype | Likely benign (Sep 21, 2019) | ||
12-8648115-AT-A | Uncertain significance (Mar 04, 2022) | |||
12-8648134-G-A | Cardiovascular phenotype | Uncertain significance (Oct 02, 2023) | ||
12-8648135-G-A | Uncertain significance (Nov 17, 2023) | |||
12-8648139-T-C | Cardiovascular phenotype | Likely benign (Nov 08, 2020) | ||
12-8648140-C-A | Uncertain significance (Jun 26, 2024) | |||
12-8648140-C-T | Cardiovascular phenotype | Uncertain significance (Nov 21, 2023) | ||
12-8648141-G-A | Aortic aneurysm, familial thoracic 9 • Isolated thoracic aortic aneurysm | Conflicting classifications of pathogenicity (Jul 17, 2023) | ||
12-8648149-T-C | Uncertain significance (Sep 04, 2023) | |||
12-8648150-T-C | Uncertain significance (Jul 14, 2022) | |||
12-8648155-C-T | Cardiovascular phenotype | Uncertain significance (May 10, 2024) | ||
12-8648158-C-T | MFAP5-related disorder | Uncertain significance (Apr 01, 2023) | ||
12-8648159-G-A | Likely benign (Jan 01, 2024) | |||
12-8648159-G-T | Cardiovascular phenotype | Uncertain significance (Jun 10, 2022) | ||
12-8648162-G-A | Cardiovascular phenotype | Uncertain significance (Nov 28, 2021) | ||
12-8648164-C-G | Uncertain significance (Oct 01, 2021) | |||
12-8648167-C-A | Cardiovascular phenotype | Uncertain significance (Apr 24, 2023) | ||
12-8648168-TA-T | Cardiovascular phenotype | Uncertain significance (Jun 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MFAP5 | protein_coding | protein_coding | ENST00000359478 | 9 | 25543 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00506 | 0.971 | 125716 | 0 | 31 | 125747 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.322 | 96 | 105 | 0.912 | 0.00000619 | 1123 |
Missense in Polyphen | 44 | 44.935 | 0.97919 | 460 | ||
Synonymous | -0.600 | 39 | 34.5 | 1.13 | 0.00000190 | 323 |
Loss of Function | 1.97 | 6 | 14.0 | 0.430 | 7.91e-7 | 147 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000908 | 0.000907 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000223 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000537 | 0.0000527 |
Middle Eastern | 0.000223 | 0.000217 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in hematopoiesis. In the cardiovascular system, could regulate growth factors or participate in cell signaling in maintaining large vessel integrity (By similarity). Component of the elastin-associated microfibrils (PubMed:8557636). {ECO:0000250|UniProtKB:Q9QZJ6, ECO:0000269|PubMed:8557636}.;
- Disease
- DISEASE: Aortic aneurysm, familial thoracic 9 (AAT9) [MIM:616166]: A disease characterized by permanent dilation of the thoracic aorta usually due to degenerative changes in the aortic wall. It is primarily associated with a characteristic histologic appearance known as 'medial necrosis' or 'Erdheim cystic medial necrosis' in which there is degeneration and fragmentation of elastic fibers, loss of smooth muscle cells, and an accumulation of basophilic ground substance. {ECO:0000269|PubMed:25434006}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- MFAP5-mediated ovarian cancer cell motility and invasiveness;Extracellular matrix organization;Molecules associated with elastic fibres;Elastic fibre formation;Notch signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.511
- rvis_EVS
- -0.34
- rvis_percentile_EVS
- 30.07
Haploinsufficiency Scores
- pHI
- 0.736
- hipred
- Y
- hipred_score
- 0.742
- ghis
- 0.584
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mfap5
- Phenotype
- skeleton phenotype; immune system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- extracellular matrix organization;definitive hemopoiesis;supramolecular fiber organization
- Cellular component
- microfibril;extracellular region;collagen-containing extracellular matrix
- Molecular function
- extracellular matrix structural constituent